Study Aims

Natural History Dataset:

  • Made available to academic and industry investigators to advance ALS care, drug development, and outcomes research.

Blood Collection:

  • Testing of exploratory biomarkers
  • Whole Genome Sequencing (performed at the American Genome Center of the Uniformed Services University)
  • Plasma, serum, and PBMC biorepository at the University of Minnesota
  • Time-to-event disease progression modeling

Study Protocol

This is a clinic-based natural history study and registry. Once the participant enrolls in the study at the clinic all data collection will occur remotely. At this point in time, we are only able to enroll patients who are currently being served by the Consortium ALS Clinics. Biospecimen (e.g. blood) collection will be done at the ALS Clinic in alignment with the participant's care schedule.

Summary of Assessments for Participants

Enrollment Visit

Follow Up Visit

Informed ConsentX 
ALS/MND History
ALS/MND History: date of first symptom, diagnosis date, site of onsetX 

MND Phenotype:

  • ALS Phenotype: bulbar-onset, respiratory-onset, limb-onset, predominantly UMN ALS, flail arm, flail leg, PMA.
  • Non-ALS Phenotypes: PBP, PLS, HSP
  • ALS at-risk
XX
Cognitive Phenotype: ALS behavioral impairment (ALSbi), ALS cognitive impairment (ALSci), ALS combined cognitive and behavioral impairment (ALScbi), ALS with frontotemporal dementia (ALS-FTD)XX
Other neurological symptoms: sensory, autonomic, otherXX
Diagnostic CriteriaX 
Family History: MND, dementia, otherX 
Genotype: positive, negative, laboratory usedX 
Demographics: DOB, Sex assigned at birth, race/ethnicity, Socioeconomic status, Educational level, Occupation, Military status, History of athletic participation, Head injuary historyX 
Medical ComorbiditiesXX
Past Surgical HistoryX 
Interim Events: Hospitalizations, Falls, Infections, Thromboses, Power wheelchair, Noninvasive ventilator (NIV) initiation, Gastrostomy placement, Hospice referral, NIV use >22 hours, Tracheostomy, Death X
Clinical Procedures and Assessments
Vital Signs: weight (kg), calculated BMIXX
Medical ExaminationXX
ALSFRS-R (ALS Participants)XX
10-meter walk testXX
Speaking rateXX
PLSFRS (PLS Participants)XX
Rasch-built Overall ALS Disability Scale (ROADS)optionaloptional
ALS Cognitive Behavioral Screen (ALS-CBS)X 
Pulmonary Testing: Upright forced vital capacityXX
Other Testing: Supine testing, MIP, MEP, peak cough flowoptionaloptional
Biofluid Collection (e.g. blood)XX